Ovarian Cancer Clinical Trials

Showing 241-260 of 902 trials

RECRUITINGPhase 2

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

NCT05200260

Optimal Timing of Surgery combined with Maintenance Therapy in the Front-line Treatment of Advanced Ovarian Cancer

Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma

Shanghai Gynecologic Oncology Group220 participantsStarted Jul 2022

Foshan, China • Guangzhou, China • Hangzhou, China +6 more locations

RECRUITINGPhase 1

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

NCT04701645

This pilot study will assess the feasibility of using an implantable microdevice to measure local intratumor response to chemotherapy and other clinically relevant drugs in ovarian, fallopian tube, and primary peritoneal cancer. The name of the study intervention involved in this study is: -implantable microdevice

Ovarian CancerFallopian Tube CancerPeritoneal Cancer+4 more

Brigham and Women's Hospital20 participantsStarted Nov 2022

Boston, Massachusetts, United States • Boston, Massachusetts, United States

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

Related Searches

Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host

Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study

The Impact of the Inflammation Index on Predicting Postoperative Complications in Ovarian Cancer

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)

Prediction of Platinum Resistance and Prognosis of High-grade Serous Ovarian Cancer

Role of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma

Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer

NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.

Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.

Comprehensive Outcomes for After Cancer Health

T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors

A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline from Stage I Invasive Ovarian Cancer

OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC